Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Marinus Pharmaceuticals Inc MRNS

Healthcare
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone). Its U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the use of... see more

Recent & Breaking News (NDAQ:MRNS)

Marinus Pharmaceuticals to Present At Credit Suisse Healthcare Conference

GlobeNewswire November 10, 2015

Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

GlobeNewswire November 6, 2015

Marinus Pharmaceuticals Announces Public Offering of Common Stock

GlobeNewswire November 5, 2015

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2015 Financial Results

GlobeNewswire October 29, 2015

Marinus Announces Clinical Development Plans for Ganaxolone Intravenous Formulation

GlobeNewswire October 29, 2015

Marinus Announces Key Initial Observations From Study in PCDH19 Female Pediatric Epilepsy

GlobeNewswire October 26, 2015

Marinus Pharmaceuticals Announces Positive End-of-Phase 2 Meeting With FDA for Ganaxolone in Focal Onset Seizures

GlobeNewswire September 9, 2015

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2015 Financial Results

GlobeNewswire August 4, 2015

Published Data Support Scientific Basis for Ganaxolone Use in PCDH19 Female Epilepsy

GlobeNewswire July 6, 2015

Marinus Pharmaceuticals to Present at JMP Securities Life Sciences Conference

GlobeNewswire June 16, 2015

Marinus Pharmaceuticals Presents Clinical Data of Ganaxolone in Pediatric Epilepsies at Antiepileptic Drug and Device Trials XIII Conference

GlobeNewswire May 18, 2015

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2015 Financial Results

GlobeNewswire May 11, 2015

Marinus Pharmaceuticals' Ganaxolone Receives FDA Orphan Drug Designation in PCDH19 Female Epilepsy

GlobeNewswire March 25, 2015

Marinus Pharmaceuticals to Participate in Future Leaders in the Biotech Industry Conference

GlobeNewswire March 16, 2015

Marinus Pharmaceuticals Provides Business Update and Reports Year End 2014 Financial Results

GlobeNewswire March 12, 2015

Marinus Pharmaceuticals to Participate in Cowen & Company Annual Healthcare Conference

GlobeNewswire February 24, 2015

Marinus Pharmaceuticals to Participate in Leerink Global Healthcare Conference

GlobeNewswire February 9, 2015

U.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum

Business Wire February 3, 2015

Marinus Pharmaceuticals Initiates Clinical Trial With Ganaxolone in PCDH19 Female Pediatric Epilepsy

GlobeNewswire February 3, 2015

Marinus Pharmaceuticals to Present at BIO CEO & Investor Conference

GlobeNewswire February 2, 2015